Apyx Medical ROE 2010-2024 | APYX
Current and historical return on equity (ROE) values for Apyx Medical (APYX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Apyx Medical ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-12-31 |
$-0.03B |
$0.01B |
-166.67% |
| 2024-09-30 |
$-0.03B |
$0.01B |
-164.38% |
| 2024-06-30 |
$-0.03B |
$0.02B |
-125.00% |
| 2024-03-31 |
$-0.02B |
$0.02B |
-81.36% |
| 2023-12-31 |
$-0.02B |
$0.03B |
-56.72% |
| 2023-09-30 |
$-0.02B |
$0.03B |
-41.38% |
| 2023-06-30 |
$-0.02B |
$0.04B |
-41.83% |
| 2023-03-31 |
$-0.02B |
$0.04B |
-49.38% |
| 2022-12-31 |
$-0.02B |
$0.04B |
-52.27% |
| 2022-09-30 |
$-0.02B |
$0.04B |
-39.58% |
| 2022-06-30 |
$-0.02B |
$0.05B |
-33.17% |
| 2022-03-31 |
$-0.02B |
$0.05B |
-29.49% |
| 2021-12-31 |
$-0.02B |
$0.05B |
-26.43% |
| 2021-09-30 |
$-0.02B |
$0.06B |
-25.32% |
| 2021-06-30 |
$-0.02B |
$0.06B |
-24.39% |
| 2021-03-31 |
$-0.02B |
$0.06B |
-25.10% |
| 2020-12-31 |
$-0.01B |
$0.06B |
-19.62% |
| 2020-09-30 |
$-0.02B |
$0.06B |
-23.53% |
| 2020-06-30 |
$-0.02B |
$0.07B |
-22.46% |
| 2020-03-31 |
$-0.02B |
$0.07B |
-20.07% |
| 2019-12-31 |
$-0.02B |
$0.07B |
-24.36% |
| 2019-09-30 |
$-0.02B |
$0.08B |
-21.95% |
| 2019-06-30 |
$0.06B |
$0.08B |
64.33% |
| 2019-03-31 |
$0.06B |
$0.08B |
83.39% |
| 2018-12-31 |
$0.06B |
$0.09B |
115.84% |
| 2018-09-30 |
$0.07B |
$0.09B |
171.79% |
| 2018-06-30 |
$0.00B |
$0.02B |
-13.64% |
| 2018-03-31 |
$0.00B |
$0.02B |
-17.78% |
| 2017-12-31 |
$-0.01B |
$0.02B |
-21.28% |
| 2017-09-30 |
$-0.01B |
$0.02B |
-20.41% |
| 2017-06-30 |
$-0.01B |
$0.02B |
-20.83% |
| 2017-03-31 |
$-0.01B |
$0.03B |
-21.51% |
| 2016-12-31 |
$-0.01B |
$0.03B |
-22.22% |
| 2016-09-30 |
$-0.01B |
$0.02B |
-22.99% |
| 2016-06-30 |
$-0.01B |
$0.02B |
-26.37% |
| 2016-03-31 |
$-0.01B |
$0.02B |
-25.00% |
| 2015-12-31 |
$0.01B |
$0.02B |
36.00% |
| 2015-09-30 |
$0.01B |
$0.03B |
24.39% |
| 2015-06-30 |
$0.00B |
$0.03B |
23.88% |
| 2015-03-31 |
$0.01B |
$0.03B |
37.74% |
| 2014-12-31 |
$-0.02B |
$0.01B |
-184.62% |
| 2014-09-30 |
$-0.02B |
$0.01B |
-130.91% |
| 2014-06-30 |
$-0.02B |
$0.01B |
-90.91% |
| 2014-03-31 |
$-0.02B |
$0.01B |
-84.21% |
| 2013-12-31 |
$-0.01B |
$0.02B |
-27.59% |
| 2013-09-30 |
$0.00B |
$0.02B |
-4.49% |
| 2013-06-30 |
$0.00B |
$0.02B |
-4.40% |
| 2013-03-31 |
$0.00B |
$0.02B |
0.00% |
| 2012-12-31 |
$0.00B |
$0.02B |
0.00% |
| 2012-09-30 |
$0.00B |
$0.02B |
-4.44% |
| 2012-06-30 |
$0.00B |
$0.02B |
-4.44% |
| 2012-03-31 |
$0.00B |
$0.02B |
-4.44% |
| 2011-12-31 |
$0.00B |
$0.02B |
-4.44% |
| 2011-09-30 |
$0.00B |
$0.02B |
-4.44% |
| 2011-06-30 |
$0.00B |
$0.02B |
-4.44% |
| 2011-03-31 |
$0.00B |
$0.02B |
-4.44% |
| 2010-12-31 |
$0.00B |
$0.02B |
-4.49% |
| 2010-09-30 |
$0.00B |
$0.02B |
0.00% |
| 2010-06-30 |
$0.00B |
$0.02B |
0.00% |
| 2010-03-31 |
$0.00B |
$0.02B |
0.00% |
| 2009-12-31 |
$0.00B |
$0.02B |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.040B |
$0.048B |
|
Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.
|
